Stock Spotlight Archives - Page 197 of 379

FridayMar 26, 2021 1:22 pm

QualityStocksNewsBreaks – Ideanomics Inc. (NASDAQ: IDEX) Furthers Strategy with Energica Investment

Ideanomics (NASDAQ: IDEX), a global company facilitating the adoption of commercial electric vehicles and supporting next-generation financial services and fintech products, has inched closer to realizing its vision with the recent acquisition of a 20% stake in Energica Motor Company S.p.A. (“Energica”), a manufacturer of high-performance electric motorcycles. The investment, amounting to approximately $13 million, is part of a strategy to bring together companies producing electric vehicles and related products or services, thus allowing technology synergies to play out among them. “The latest investment, Energica, will be part of Ideanomics’ Mobility division and is the second of its kind for…

FridayMar 26, 2021 1:15 pm

QualityStocksNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Subsidiary LD Micro a Revered Brand in the Microcap Space

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has lauded the president of LD Micro, its recently acquired subsidiary, and his team for creating a loyal community of investors and issuers. The president, Chris Lahiji, “founded LD Micro as an independent resource to the microcap world in 2006, growing it quickly to become the premier event platform in the space,” reads an article detailing a recent SRAX announcement on the growth of LD Micro’s microcap index. “Following the identification of potential synergies with Sequire, LD micro…

FridayMar 26, 2021 12:57 pm

QualityStocksNewsBreaks – Healthtech Solutions Inc.’s (HLTT) Technology Enables Rapid Evaluation of COVID-19’s Damaging Effects

Healthtech Solutions (OTC: HLTT), through its subsidiary, Mediscan Inc., offers cloud-based software for ultrasound that has proven to be effective in evaluating internal organs affected by COVID-19. “COVID-19 has shown a propensity to affect an individual’s body in a number of different ways, including the long-term health of a patient’s cardiovascular and pulmonary system,” reads an article discussing the company’s solution. “As such, the need to properly diagnose lung infections, which could otherwise be sustained throughout a patient’s life, or myocarditis, an inflammation of the heart muscles, which could go undiscovered if not properly diagnosed, has heightened the need for…

FridayMar 26, 2021 12:24 pm

QualityStocksNewsBreaks – Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Breakthrough Technology Rectifies Cystoscopy Limitations

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, has developed proprietary technology that solves the issues associated with existing cystoscopies. “White light images show the full landscape of the bladder but do not effectively highlight cancer,” reads an article about the benefits of the i/Blue Imaging(TM) System, Imagin Medical’s proprietary technology. “A promising new modality, blue light cystoscopy, uses blue-filtered white light to detect flat tumors and cancerous cells not seen with white light. However, surgeons can’t operate using blue light images. The blue images aren’t in real-time, orientation in the bladder is easily lost, and the surgeon…

ThursdayMar 25, 2021 2:19 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Continues to Advance Toward Clinical Trials

CNS Pharmaceuticals (NASDAQ: CNSP) recently announced that the Wroclaw, Poland-based Lower Silesian Medical Chamber Ethics Committee gave WPD Pharmaceuticals (CSE: WBIO) (Frankfurt: 8SV1) (“WPD”), the company’s sublicensee in Europe and Asia for its lead drug candidate, Berubicin, a positive opinion for its WPD-201 Clinical Trial Protocol. The protocol will be used in the planned forthcoming Berubicin clinical trial in adults with glioblastoma multiforme (“GBM”). This new development set the wheels in motion for the eventual approval of WPD’s studies — a multicenter Berubicin Phase 2 adult GBM trial and a multicenter pediatric Phase 1 malignant glioma trial. “WPD plans to…

ThursdayMar 25, 2021 1:38 pm

QualityStocksNewsBreaks – Mobius Interactive Ltd. Looks to Bright Future in Gaming Industry, Backed by New Technologies

Mobius Interactive, an online gaming operator featuring unique offerings for diverse demographic groups, is excited about the potential benefits of the new technologies being integrated into the gaming industry. In an interview with G&M News, Mobius Interactive’s co-founder and COO Robin Lawson discussed “significant changes in the online gaming community, from unprecedented growth during 2020 due to the pandemic and lockdowns to the use of blockchain and bitcoin in the gaming industry.” The article reporting the interview quotes Lawson as saying, “We are seeing improved payments on betting with cryptocurrencies like bitcoin, which is one of a number of crypto…

ThursdayMar 25, 2021 1:10 pm

QualityStocksNewsBreaks – Healthy Extracts Inc. (HYEX) Achieves Strong Growth Amid Booming Market

Healthy Extracts (OTCQB: HYEX), a leading developer and manufacturer of heart health, brain health and supplementary technologies, reported a revenue increase of 71% from $748,377 in 2019 to $1,276,559 over the 12 months ending December 31, 2020. The company attributes this growth to the transition to its new business selling health nutrition products, which positions HYEX for opportunity in the booming plant-based foods and products industry projected to reach $74.2 billion in 2027. “We changed our name from Grey Cloak Tech Inc. to Healthy Extracts Inc. to more accurately reflect our business,” a recent article quotes Kevin Duke Pitts, director,…

ThursdayMar 25, 2021 12:44 pm

QualityStocksNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) Eyes Strong Profit Potential with High-Priority Targets

GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF), a Canadian junior exploration company, has acquired seven advanced gold projects located in the prolific Maricunga Gold Belt in Northern Chile. Four of these are categorized as high-priority sites, positioning the company favorably as gold prices reached historic highs in 2020, topping $2,000 per ounce, and continue to trend upward. Wallet Investors projects that gold will rise over the next five years, surpassing $3,100 per ounce by 2026 (https://ibn.fm/2NJHh). “GoldHaven has strong profit potential with four high-priority targets,” reads a recent article discussing the company’s prospects. “Its Rio Loa Project has entered phase 1…

ThursdayMar 25, 2021 11:32 am

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSXV: ISGI) (OTCQB: ISGIF) Is a Disruptor in the Changing Insurance Marketplace

InsuraGuest Technologies (TSXV: ISGI) (OTCQB: ISGIF), an innovative insurtech (insurance+technology) provider, is transforming the way coverage is delivered. The company leverages its proprietary software platform to deliver digital insurance to multiple sectors, distinguishing itself across the changing landscape of the insurance industry. A McKinsey report discusses digital disruption of the sector and the age of innovation, where insurers have a choice whether to “be disrupted or be the disruptor with new products, services and business models” (https://ibn.fm/aAcex). InsuraGuest’s platform and product offerings clearly position it as a disruptor amid marketplace trends. A recent article discussing this reads, “Further, ISGIF’s software…

WednesdayMar 24, 2021 1:31 pm

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Working to Expand Test Portfolio

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), which recently received European approval for its COVID-19 rapid and portable test system, has set out to increase its portfolio of tests for different diseases to help fight the current and potential pandemics. XPhyto has partnered with Germany’s 3a-diagnostics GmbH for this, according to an article on the company’s recent announcements. “The company is also working with 3a to develop a portfolio of oral biosensor screening tests that detect bacterial and viral infectious diseases ranging from influenza A to group A strep, as well as focusing on other potential pandemic biosensor tech…

Site Search

Company Search

Category: Stock Spotlight